QUODD

Insider Transactions last 24 months for Better Therapeutics, Inc. - OTC: BTTX

Transactions
All	Buy	Sell	Option Exercise

Filer's Name	Relationship/ Title	Trans. Date	Trans. Type	Ownership Type	Security Type	Shares	Price	Trans. Value	Total Shares Owned
Perry David P	Executive Chairman	02/09/2024	AA	Direct	COM	839,895	$0.19	$160,000.00	2,416,634
Perry David P	Executive Chairman	01/09/2024	AA	Direct	COM	1,471,453	$0.17	$249,999.86	1,576,739
Berman Mark A.	Chief Medical Officer	12/18/2023	AA	Direct	COM	25,362	$0.00	$0.00	448,140
Karbe Frank	Chief Executive Officer	12/18/2023	AA	Direct	COM	62,500	$0.00	$0.00	526,516
Granger Elder	Director	12/18/2023	AA	Direct	COM	3,750	$0.00	$0.00	39,601
Miller Leslie A.	Principal Accounting Officer	12/18/2023	AA	Direct	COM	3,587	$0.00	$0.00	17,937
Armanino Andrew J.	Director	12/18/2023	AA	Direct	COM	3,750	$0.00	$0.00	17,084
Parker Geoffrey M.	Director	12/18/2023	AA	Direct	COM	3,750	$0.00	$0.00	1,031,805
Wynholds Kristin	Chief Product Officer	12/18/2023	AA	Direct	COM	25,362	$0.00	$0.00	225,631
Lavizzo-Mourey Risa J	Director	12/18/2023	AA	Direct	COM	3,750	$0.00	$0.00	13,750
Carmona Richard H	Director	12/18/2023	AA	Direct	COM	3,750	$0.00	$0.00	157,369
Perry David P	Executive Chairman	12/18/2023	AA	Direct	COM	3,750	$0.00	$0.00	105,286

1 You are at page 1 of 1 pages

Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security \| D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) \| E = Expiration of short derivative position \| F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. \| G = Gift \| H = Expiration (or cancellation) of long derivative position with value received \| I = Discretionary transaction in accordance with Rule 16b-3(f) \| J = Other \| L = Small acquisition under Rule 16a-6 \| M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 \| O = Exercise of out-of-the-money derivative security \| P = Open market or private purchase \| S = Open market or private sale \| U = Disposition pursuant to a tender of shares in a change of control transaction \| W = Acquisition or disposition by will or the laws of descent and distribution \| X = Exercise of in-the-money or at-the-money derivative security \| Z = Deposit into or withdrawal from voting trust		Send to Excel

Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust

Send to Excel